While it has been widely accepted that CNS inflammation in MS patients is mediated mainly by the IFN-γ-secreting Th1 cells, in recent years, Th17 cells have emerged as major players in MS due to their high pathogenic potential through the production of proinflammatory cytokine IL-17A. The gene discussed is IFNG; the disease is myeloid sarcoma.